Rhinitis, Allergic, Perennial
Information
- Disease name
- Rhinitis, Allergic, Perennial
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03286049 | Completed | Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age | January 10, 2018 | July 31, 2018 | |
| NCT00092118 | Completed | Phase 3 | The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) | October 2003 | May 2004 |
| NCT00103454 | Completed | Phase 3 | A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). | January 2005 | May 2005 |
| NCT00107757 | Completed | Phase 3 | Seasonal Allergic Rhinitis In Pediatric Subjects | March 2005 | November 2005 |
| NCT00108914 | Completed | Phase 3 | Perennial Allergic Rhinitis Study In Pediatric Subjects | February 2005 | November 2005 |
| NCT00116818 | Completed | Phase 3 | A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults | January 2005 | May 2005 |
| NCT00116883 | Completed | Phase 3 | A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics | February 2005 | July 2005 |
| NCT02339714 | Completed | Phase 2 | Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis | March 2015 | June 2018 |
| NCT02443805 | Completed | Phase 3 | Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR | September 29, 2015 | June 25, 2018 |
| NCT02498509 | Completed | Phase 3 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 | May 2015 | May 2016 |
| NCT02682745 | Completed | Phase 1 | Single Dosing Clinical Trial of HL151 | January 15, 2016 | February 12, 2016 |
| NCT02686294 | Completed | Phase 1 | Repeated Dosing Clinical Trial of HL151 | February 16, 2016 | March 15, 2016 |
| NCT00092105 | Completed | Phase 3 | Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) | April 1, 2002 | January 28, 2003 |
| NCT00132925 | Completed | Phase 3 | An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis | November 2003 | February 2006 |
| NCT00159523 | Completed | N/A | Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic | December 2003 | September 2007 |
| NCT00160589 | Completed | Phase 4 | LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) | April 2005 | September 2005 |
| NCT00160680 | Completed | Phase 4 | ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) | March 1, 2005 | June 1, 2006 |
| NCT00224523 | Completed | Phase 3 | Long Term Safety Of GW685698X Via Nasal Biopsy | September 2005 | February 2007 |
| NCT00232518 | Completed | N/A | Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis | September 2005 | November 2006 |
| NCT00253058 | Completed | Phase 3 | Study Of Perennial Allergic Rhinitis In Pediatrics | July 2005 | |
| NCT00257595 | Completed | Phase 3 | Perennial Allergic Rhinitis In Pediatric Subjects | August 2005 | |
| NCT00289198 | Completed | Phase 3 | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) | February 7, 2006 | July 4, 2006 |
| NCT00346775 | Completed | Phase 3 | Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) | May 1, 2006 | June 29, 2006 |
| NCT00398476 | Completed | Phase 3 | Fluticasone Nasal Spray Patient Preference Study | December 1, 2006 | December 4, 2006 |
| NCT00404586 | Completed | Phase 1 | Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber | September 11, 2006 | January 16, 2007 |
| NCT00406783 | Completed | Phase 3 | Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) | August 2006 | November 2007 |
| NCT00449072 | Completed | Phase 4 | Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) | March 2007 | October 2011 |
| NCT00490204 | Completed | Phase 3 | Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis | July 27, 2007 | October 3, 2007 |
| NCT00519636 | Completed | Phase 4 | Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS | August 2007 | November 2007 |
| NCT00539006 | Completed | Phase 4 | Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS | August 2007 | November 2007 |
| NCT00570492 | Completed | Phase 4 | Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. | November 26, 2007 | March 17, 2011 |
| NCT00609674 | Completed | Phase 4 | A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis | January 2008 | June 2008 |
| NCT00639587 | Completed | Phase 3 | Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis | August 2002 | March 2003 |
| NCT00658918 | Completed | Phase 3 | To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) | September 2004 | November 2005 |
| NCT00659048 | Completed | Phase 3 | Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) | December 2004 | December 2005 |
| NCT00659750 | Completed | Phase 3 | To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) | December 2003 | April 2005 |
| NCT00682643 | Completed | Phase 4 | A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis | June 2008 | February 2011 |
| NCT00730756 | Completed | Phase 2 | A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis | March 2008 | February 2009 |
| NCT00741897 | Completed | Phase 4 | Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis | March 2002 | |
| NCT00761527 | Completed | Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) | March 2008 | May 2010 | |
| NCT00762983 | Completed | Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) | March 2008 | February 2009 | |
| NCT00779545 | Completed | Phase 2 | A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) | April 8, 2004 | August 6, 2004 |
| NCT00779740 | Completed | Phase 3 | Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) | February 1, 2005 | April 1, 2005 |
| NCT00806754 | Completed | Phase 4 | Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) | November 2006 | August 2007 |
| NCT00829985 | Completed | Phase 1/Phase 2 | Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) | January 2009 | December 2009 |
| NCT00839189 | Completed | Phase 1 | Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults | October 2002 | June 2006 |
| NCT00848965 | Completed | Phase 4 | A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber | October 2007 | January 2008 |
| NCT00988247 | Completed | Phase 3 | Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis | October 31, 2009 | February 28, 2011 |
| NCT01077609 | Completed | Flixonase Safety in Patients With Allergic Rhinitis (AR) | January 2008 | April 2010 | |
| NCT01115595 | Completed | Phase 4 | Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais | March 2010 | October 2014 |
| NCT01134705 | Completed | Phase 3 | Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) | May 2010 | October 2010 |
| NCT01135134 | Completed | Phase 3 | Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) | June 2010 | October 2010 |
| NCT01165424 | Completed | Phase 3 | A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) | April 2010 | December 2010 |
| NCT01199757 | Completed | A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures | July 10, 2009 | August 1, 2009 | |
| NCT01216384 | Completed | Phase 1 | Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers | October 2010 | |
| NCT01231464 | Completed | Phase 3 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis | September 2009 | July 2010 |
| NCT01270958 | Completed | Phase 4 | A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis | August 2009 | February 2010 |
| NCT01630135 | Completed | Phase 3 | Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis | June 2012 | August 2012 |
| NCT01644617 | Completed | Phase 2 | A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) | October 2012 | August 2013 |
| NCT01678807 | Completed | Phase 1 | Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) | October 2012 | May 2013 |
| NCT01700192 | Completed | Phase 3 | Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) | January 2013 | April 2015 |
| NCT01779895 | Completed | N/A | Probiotic Administration and Perennial Allergic Rhinitis | December 2012 | September 2013 |
| NCT02182518 | Completed | Phase 3 | Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis | May 2000 | |
| NCT02182544 | Completed | Phase 3 | WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis | June 2001 | |
| NCT02238223 | Completed | Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet | April 2004 | ||
| NCT02238236 | Completed | Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus | May 2005 | ||
| NCT00119015 | Terminated | Phase 4 | The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis | July 2005 | January 2009 |
| NCT01172613 | Unknown status | Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population | June 2010 | ||
| NCT00153595 | Unknown status | Phase 2/Phase 3 | EWO1 in Persistent Allergic Rhinitis Patients | November 2004 | |
| NCT02653339 | Unknown status | N/A | Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis. | June 2016 | August 2018 |
| NCT02988778 | Withdrawn | Phase 3 | Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis | October 8, 2019 | October 8, 2019 |
| NCT02972866 | Withdrawn | Phase 3 | Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis | June 2016 | November 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012221